ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of steroidogenic factor-1 (SF-1, NR5A1) in the human adrenal gland

FASEB Journal

Volumn 25, Issue 4, 2011, Pages 1166-1175

  Ferraz De souza, Bruno ^a   Lin, Lin ^a   Shah, Sonia ^c   Jina, Nipurna ^b   Hubank, Mike ^b   Dattani, Mehul T ^a   Achermann, John C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adrenal development; Adrenal tumorigenesis; Angiogenesis; NCI H295R adrenocortical cells; Transcriptional regulation

Indexed keywords

ANGIOPOIETIN 2; LUCIFERASE; STEROIDOGENIC FACTOR 1;

ADRENAL CORTEX CELL; ADRENAL GLAND; ARTICLE; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING;

ADENOCARCINOMA; ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ANGIOPOIETIN-2; BINDING SITES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRESSOR PROTEINS; STEROIDOGENIC FACTOR 1; TRANS-ACTIVATORS;

EID: 79954572300     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-170522     Document Type: Article

References (50)

1. Schimmer, B. P., and White, P. C. (2010) Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. Mol. Endocrinol. 24, 1322-1337
2. Ferraz-de-Souza, B., Lin, L., and Achermann, J. C (2010) Steroidogenic factor-1 (SF-1, NR5A1) and human disease. [E-pub ahead of print] Mol. Cell. Endocrinol. doi: 10.1016/j.mce. 2010. 11.006
3. Ikeda, Y., Shen, W. H., Ingraham, H. A., and Parker, K. L. (1994) Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol. Endocrinol. 8, 654-662 (Pubitemid 24174502)
4. Ramayya, M. S., Zhou, J., Kino, T., Segars, J. H., Bondy, C. A., and Chrousos, G. P. (1997) Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: northern blot and in situ hybridization studies. J. Clin. Endocrinol. Metab. 82, 1799-1806 (Pubitemid 127495189)
5. Luo, X., Ikeda, Y., and Parker, K. L. (1994) A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77, 481-490 (Pubitemid 24153989)
6. Shinoda, K., Lei, H., Yoshii, H., Nomura, M., Nagano, M., Shiba, H., Sasaki, H., Osawa, Y., Ninomiya, Y., Niwa, O., Morohashi, K.-I., and Li, E. (1995) Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev. Dyn. 204, 22-29
7. Sadovsky, Y., Crawford, P. A., Woodson, K. G., Polish, J. A., Clements, M. A., Tourtellotte, L. M., Simburger, K., and Milbrandt, J. (1995) Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. U. S. A. 92, 10939-10943
8. Achermann, J. C., Ito, M., Ito, M., Hindmarsh, P. C., and Jameson, J. L. (1999) A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat. Genet. 22, 125-126 (Pubitemid 29264799)
9. Achermann, J. C., Ozisik, G., Ito, M., Orun, U. A., Harmanci, K., Gurakan, B., and Jameson, J. L. (2002) Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J. Clin. Endocrinol. Metab. 87, 1829-1833 (Pubitemid 34615276)
10. Biason-Lauber, A., and Schoenle, E. J. (2000) Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am. J. Hum. Genet. 67, 1563-1568
11. Lalli, E. (2010) Adrenocortical development and cancer: focus on SF-1. J. Mol. Endocrinol. 44, 301-307
12. Figueiredo, B. C., Cavalli, L. R., Pianovski, M. A., Lalli, E., Sandrini, R., Ribeiro, R. C., Zambetti, G., DeLacerda, L., Rodrigues, G. A., and Haddad, B. R. (2005) Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J. Clin. Endocrinol. Metab. 90, 615-619 (Pubitemid 40279170)
13. Almeida, M. Q., Soares, I. C., Ribeiro, T. C., Fragoso, M. C., Marins, L. V., Wakamatsu, A., Ressio, R. A., Nishi, M. Y., Jorge, A. A., Lerario, A. M., Alves, V. A., Mendonca, B. B., and Latronico, A. C. (2010) Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. J. Clin. Endocrinol. Metab. 95, 1458-1462
14. Sbiera, S., Schmull, S., Assie, G., Voelker, H. U., Kraus, L., Beyer, M., Ragazzon, B., Beuschlein, F., Willenberg, H. S., Hahner, S., Saeger, W., Bertherat, J., Allolio, B., and Fassnacht, M. (2010) High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. J. Clin. Endocrinol. Metab. 95, E161-171
15. Doghman, M., Karpova, T., Rodrigues, G. A., Arhatte, M., De Moura, J., Cavalli, L. R., Virolle, V., Barbry, P., Zambetti, G. P., Figueiredo, B. C., Heckert, L. L., and Lalli, E. (2007) Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and Cancer. Mol. Endocrinol. 21, 2968-2987 (Pubitemid 350223508)
16. Ren, B., Robert, F., Wyrick, J. J., Aparicio, O., Jennings, E. G., Simon, I., Zeitlinger, J., Schreiber, J., Hannett, N., Kanin, E., Volkert, T. L., Wilson, C. J., Bell, S. P., and Young, R. A. (2000) Genome-wide location and function of DNA binding proteins. Science 290, 2306-2309 (Pubitemid 32041573)
17. Oberley, M. J., Tsao, J., Yau, P., and Farnham, P. J. (2004) High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol. 376, 315-334 (Pubitemid 38200188)
18. Ji, H., Jiang, H., Ma, W., Johnson, D. S., Myers, R. M., and Wong, W. H. (2008) An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat. Biotechnol. 26, 1293-1300
19. Ji, H., Vokes, S. A., and Wong, W. H. (2006) A comparative analysis of genome-wide chromatin immunoprecipitation data for mammalian transcription factors. Nucleic Acids Res. 34, e146
20. Ji, H., and Wong, W. H. (2005) TileMap: create chromosomal map of tiling array hybridizations. Bioinformatics 21, 3629-3636 (Pubitemid 41264098)
21. Nicol, J. W., Helt, G. A., Blanchard, S. G., Jr., Raja, A., and Loraine, A. E. (2009) The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets. Bioinformatics 25, 2730-2731
22. Ito, M., Achermann, J. C., and Jameson, J. L. (2000) A naturally occurring steroidogenic factor-1 mutation exhibits differential binding and activation of target genes. J. Biol. Chem. 275, 31708-31714
23. Hu, M. C., Hsu, N. C., Pai, C. I., Wang, C. K., and Chung, B. (2001) Functions of the upstream and proximal steroidogenic factor 1 (SF-1)-binding sites in the CYP11A1 promoter in basal transcription and hormonal response. Mol. Endocrinol. 15, 812-818 (Pubitemid 32411318)
24. Gizard, F., Lavallee, B., DeWitte, F., Teissier, E., Staels, B., and Hum, D. W. (2002) The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells. J. Biol. Chem. 277, 39144-39155 (Pubitemid 35190882)
25. Guo, I. C., Shih, M. C., Lan, H. C., Hsu, N. C., Hu, M. C., and Chung, B. C. (2007) Transcriptional regulation of human CYP11A1 in gonads and adrenals. J. Biomed. Sci. 14, 509-515
26. Val, P., Martinez-Barbera, J. P., and Swain, A. (2007) Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development 134, 2349-2358 (Pubitemid 47010023)
27. Ferraz-de-Souza, B., Martin, F., Mallet, D., Hudson-Davies, R. E., Cogram, P., Lin, L., Gerrelli, D., Beuschlein, F., Morel, Y., Huebner, A., and Achermann, J. C. (2009) CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease. J. Clin. Endocrinol. Metab. 94, 678-683
28. Untergasser, A., Nijveen, H., Rao, X., Bisseling, T., Geurts, R., and Leunissen, J. A. (2007) Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res. 35, W71-74
29. Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., Frisch, M., Bayerlein, M., and Werner, T. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21, 2933-2942 (Pubitemid 40916416)
30. West, A. N., Neale, G. A., Pounds, S., Figueredo, B. C., Rodriguez Galindo, C., Pianovski, M. A., Oliveira Filho, A. G., Malkin, D., Lalli, E., Ribeiro, R., and Zambetti, G. P. (2007) Gene expression profiling of childhood adrenocortical tumors. Cancer Res. 67, 600-608 (Pubitemid 46192198)
31. Giordano, T. J., Kuick, R., Else, T., Gauger, P. G., Vinco, M., Bauersfeld, J., Sanders, D., Thomas, D. G., Doherty, G., and Hammer, G. (2009) Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin. Cancer Res. 15, 668-676
32. Soon, P. S., Gill, A. J., Benn, D. E., Clarkson, A., Robinson, B. G., McDonald, K. L., and Sidhu, S. B. (2009) Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocr. Relat. Cancer 16, 573-583
33. Goto, M., Piper Hanley, K., Marcos, J., Wood, P. J., Wright, S., Postle, A. D., Cameron, I. T., Mason, J. I., Wilson, D. I., and Hanley, N. A. (2006) In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J. Clin. Invest. 116, 953-960
34. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. (2000) Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248
35. Papetti, M., and Herman, I. M. (2002) Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol. 282, C947-C970 (Pubitemid 34663101)
36. Bach, F., Uddin, F. J., and Burke, D. (2007) Angiopoietins in malignancy. Eur. J. Surg. Oncol. 33, 7-15 (Pubitemid 46156618)
37. Ishimoto, H., Ginzinger, D. G., and Jaffe, R. B. (2006) Adrenocorticotropin preferentially up-regulates angiopoietin 2 in the human fetal adrenal gland: implications for coordinated adrenal organ growth and angiogenesis. J. Clin. Endocrinol. Metab. 91, 1909-1915
38. Ishimoto, H., Minegishi, K., Higuchi, T., Furuya, M., Asai, S., Kim, S. H., Tanaka, M., Yoshimura, Y., and Jaffe, R. B. (2008) The periphery of the human fetal adrenal gland is a site of angiogenesis: zonal differential expression and regulation of angiogenic factors. J. Clin. Endocrinol. Metab. 93, 2402-2408 (Pubitemid 351831564)
39. Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., and Vinson, G. P. (1998) Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr. Rev. 19, 101-143 (Pubitemid 29114288)
40. Bland, M. L., Jamieson, C. A., Akana, S. F., Bornstein, S. R., Eisenhofer, G., Dallman, M. F., and Ingraham, H. A. (2000) Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc. Natl. Acad. Sci. U. S. A. 97, 14488-14493 (Pubitemid 32016603)
41. Zhao, Y., and Bruemmer, D. (2010) NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler. Thromb. Vasc. Biol. 30, 1535-1541
42. Gruber, F., Hufnagl, P., Hofer-Warbinek, R., Schmid, J. A., Breuss, J. M., Huber-Beckmann, R., Lucerna, M., Papac, N., Harant, H., Lindley, I., de Martin, R., and Binder, B. R. (2003) Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha-induced PAI-1 expression. Blood 101, 3042-3048 (Pubitemid 36857993)
43. Zeng, H., Qin, L., Zhao, D., Tan, X., Manseau, E. J., Van Hoang, M., Senger, D. R., Brown, L. F., Nagy, J. A., and Dvorak, H. F. (2006) Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J. Exp. Med. 203, 719-729
44. Bland, M. L., Fowkes, R. C., and Ingraham, H. A. (2004) 1Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. Mol. Endocrinol. 18, 941-952 (Pubitemid 38429483)
45. Krude, H., Schutz, B., Biebermann, H., von Moers, A., Schnabel, D., Neitzel, H., Tonnies, H., Weise, D., Lafferty, A., Schwarz, S., DeFelice, M., von Deimling, A., van Landeghem, F., DiLauro, R., and Gruters, A. (2002) Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J. Clin. Invest. 109, 475-480 (Pubitemid 34171778)
46. Gudmundsson, J., Sulem, P., Gudbjartsson, D. F., Jonasson, J. G., Sigurdsson, A., Bergthorsson, J. T., He, H., Blondal, T., Geller, F., Jakobsdottir, M., Magnusdottir, D. N., Matthiasdottir, S., Stacey, S. N., Skarphedinsson, O. B., Helgadottir, H., Li, W., Nagy, R., Aguillo, E., Faure, E., Prats, E., Saez, B., Martinez, M., Eyjolfsson, G. I., Bjornsdottir, U. S., Holm, H., Kristjansson, K., Frigge, M. L., Kristvinsson, H., Gulcher, J. R., Jonsson, T., Rafnar, T., Hjartarsson, H., Mayordomo, J. I., de la Chapelle, A., Hrafnkelsson, J., Thorsteinsdottir, U., Kong, A., and Stefansson, K. (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet. 41, 460-464
47. Sunthornthepvarakui, T., Gottschalk, M. E., Hayashi, Y., and Refetoff, S. (1995) Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N. Engl. J. Med. 332, 155-160
48. Parma, J., Duprez, L., Van Sande, J., Cochaux, P., Gervy, C., Mockel, J., Dumont, J., and Vassart, G. (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365, 649-651 (Pubitemid 23350535)
49. Kremer, H., Kraaij, R., Toledo, S. P., Post, M., Fridman, J. B., Hayashida, C. Y., van Reen, M., Milgrom, E., Ropers, H. H., Mariman, E., Themmen, A. P. N., and Brunner, H. G. (1995) Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat. Genet. 9, 160-164
50. Liu, G., Duranteau, L., Carel, J. C., Monroe, J., Doyle, D. A., and Shenker, A. (1999) Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N. Engl. J. Med. 341, 1731-1736